Status:
RECRUITING
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Breast Cancer
Eligibility:
All Genders
3+ years
Brief Summary
Background: \- Some genes may be associated with a greater chance of side effects during cancer treatment. These genes may also make certain treatments less effective. Researchers want to collect blo...
Detailed Description
Background: * Genetic polymorphisms in drug-metabolizing enzymes, transporters/receptors might affect an individual's response to drug therapy. * Inter-individual differences in efficacy and toxicity...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Any individual currently enrolled in an NIH intramural research program clinical trials receiving treatment.
- Ability of participant or Legally Authorized Representative (LAR) to understand and be willing to sign the informed consent document.
- Age \>= 3 years old
- EXCLUSION CRITERIA:
- N/A
Exclusion
Key Trial Info
Start Date :
May 21 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT01441089
Start Date
May 21 2012
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892